Evidence map›Paper›PMID 40718828›Full record

ArticleFrontiers in oncology2025

Case Report: A rare case of hemorrhagic cystic IPAS masquerading as pancreatic neoplasm.

Chong-Yuan Chen, Yu Yang, Ming-Zheng Hu, Rong-Chun Xing

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chong-Yuan ChenThe First College of Clinical Medical Science, China Three Gorges University, Hubei Yichang, China.
Yu YangThe First College of Clinical Medical Science, China Three Gorges University, Hubei Yichang, China.
Ming-Zheng HuThe First College of Clinical Medical Science, China Three Gorges University, Hubei Yichang, China.
Rong-Chun XingThe First College of Clinical Medical Science, China Three Gorges University, Hubei Yichang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intrapancreatic accessory spleen (IPAS) is a rare congenital developmental anomaly that is typically benign and does not require specific treatment. However, when IPAS undergoes hemorrhage and subsequent cystic degeneration, its clinical symptoms and laboratory findings often lack specificity, and imaging studies can be misleading, frequently resulting in misdiagnosis as pancreatic tumors or other lesions. This poses significant challenges for preoperative diagnosis. We report a case of a 53-year-old woman presenting with vague upper abdominal pain. Preoperative imaging strongly suggested a mucinous cystic neoplasm of the pancreas. However, postoperative pathology following laparoscopic distal pancreatectomy combined with splenectomy confirmed hemorrhagic cystic degeneration of an IPAS. This case highlights the importance of considering hemorrhagic cystic IPAS in the differential diagnosis of pancreatic space-occupying lesions, particularly when imaging findings are atypical or inconclusive. Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is a safe and effective method for obtaining a pathological diagnosis. Enhanced awareness of this condition, combined with meticulous radiological evaluation and necessary histopathological biopsy, can reduce misdiagnosis, avoid unnecessary surgical trauma, and improve individualized treatment strategies.

Indexed as

differential diagnosishemorrhagic cystic degenerationIntrapancreatic accessory spleenlaparoscopic distal pancreatectomymucinous cystic neoplasmpancreatic neoplasm

Identifiers

PMID40718828
PMCPMC12289690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.